Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock
Outset Medical Reports Second Quarter 2024 Financial Results
NEC Bio Therapeutics and AGC Biologics Announce Collaboration to[...]
08/08/2024 | Press release | Distributed by Public on 08/08/2024 09:07
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact